Probiotics for induction of remission in Crohn's disease

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2008, Pages

  Butterworth, Andrew D ^a   Thomas, Adrian G ^a   Akobeng, Anthony Kwaku ^b  

^a BOOTH HALL CHILDREN S HOSPITAL   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CORTICOSTEROID; LACTOBACILLUS GG; METRONIDAZOLE; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

AUTHOR; CALCULATION; CINAHL; CLINICAL TRIAL; COCHRANE LIBRARY; COMPARATIVE STUDY; CROHN DISEASE; DATA ANALYSIS; DATA EXTRACTION; DRUG EFFICACY; EMBASE; HUMAN; INFORMATION PROCESSING; INTERVENTION STUDY; MEDICAL RESEARCH; MEDLINE; METHODOLOGY; OUTCOME ASSESSMENT; REMISSION; REVIEW; RISK; SEPSIS;

EID: 55049120552     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006634.pub2     Document Type: Review

References (31)

1. Schultz 2004{published data only} Schultz M, Timmer A, Herfarth HH, Sartor RB, Vanderhoof JA, Rath HC. Lactobacillus GG in inducing and maintaining remission of Crohn's disease. BMC Gastroenterol 2004;4(5).
2. Barclay 1992{published data only} Barclay GR, McKenzie H, Pennington J, Parratt D, Pennington CR. The effect of dietary yeast on the activity of stable Crohn's disease. Scand J Gastroenterol 1992;27:196-200.
3. Bousvaros 2005{published data only} Bousvaros A, Guandalini S, Baldassano RN, Botelho C, Evans J, Ferry GD, et al.A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm Bowel Dis 2005;11:833-8.
4. Chapman 2006{published data only} Chapman T, Plosker GL, Figgitt DP. VSL#3 Probiotic mixture. A review of its use in chronic inflammatory bowel diseases. Drugs 2006;66(10):1371-87.
5. Ewaschuk 2006{published data only} Ewaschuk JB, Dieleman LA. Probiotics and prebiotics in chronic inflammatory bowel diseases. World J Gastroenterol 2006;12(37):5941-50.
6. Gionchetti 2001{published data only} Gionchetti P, Rizello F, Campieri M. Probiotics and antibiotics in inflammatory bowel disease. Curr Opin Gastroenterol 2001;17:331-5.
7. Guandalini 2002{published data only} Guandalini S. Use of Lactobaccilus-GG in paediatric Crohn's disease. Digest Liver Dis 2002;34(Suppl.2):s63-5.
8. Gupta 2000{published data only} Gupta P, Andrew A, Kirschner BS, Guandalini S. Is Lacotbaccillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr 2000;31:453-7.
9. Mach 2006{published data only} Mach T. Clnical usefulness of probiotics in inflammatory bowel diseases. J Physiol Pharmacaol 2006;57(Suppl. 9):23-33.
10. Marteau 2006{published data only} Marteau P, Lemann M, Seksik P, Laharie D, Colombei JF, Bouhnik Y, et al.Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. Gut 2006;55:842-7.
11. Plein 1993{published data only} Plein K, Hotz J. Therapeutic effects if Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhoea - a pilot study. Z Gastroenterol 1993;31:129-34.
12. Prantera 2002{published data only} Prantera C, Scribano ML, Falasco G, Andreoli A, Luza C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 2002;51:405-9.
13. Wildt 2006{published data only} Wildt S, Munck LK, Vinter-Jensen L, Hansen BF, Nordgaard-Lassen I, Christensen S, et al.Probiotic Treatment of Collagenous Colitis: A randomised, double-blind, placebo controlled trial with Lactobaccillus acidophilus and Bifidobacterium animalis subsp. Lactis. Inflamm Bowel Dis 2006;12(5):395-401.
14. Alderson 2004 Alderson P, Green S, Higgins JPT. Assessment of study quality. Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]; Section 6. In: The Cochrane Library, Issue 1. Chichester, UK: John Wiley & Sons, Ltd, 2004.
15. Campieri 2000 Campieri M, Rizzello F, Venturi A, Poggioli G, Ugolini F, Helwig U, et al.Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease: a randomized controlled study vs mesalamine. Gastroenterology 2000;118:A4179.
16. Gionchetti 2000 Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, et al.Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000;119:305-9.
17. Guslandi 2000 Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci 2000;45:1462-4.
18. Hove 1999 Hove H, Norgaard H, Mortensen PB. Lactic acid bacteria and the human gastrointestinal tract.. Eur J Clin Nutr 1999;53:339-50.
19. Isolauri 2000 Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000;30:1605-10.
20. Jadad 1996 Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al.Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996;17:1-12.
21. Kruis 1997 Kruis, W. Schutz, E. Fric, P. Fixa, B. Judmaier, G. Stolte, M. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1997;11:853-8.
22. Majamaa 1997 Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997;99:179-86.
23. Malchow 1997 Malchow HA. Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?. J Clin Gastroenterol 1997;25:653-8.
24. Malin 1996 M Malin, H Suomalainen, M Saxelin, E Isolauri. Promotion of IgA immune response in patients with Crohn's disease by oral bacterio-therapy with Lactobacillus GG. Ann Nutr Metab 1996;40:137-45.
25. Pedone 1999 Pedone CA, Bernabeu AO, Postaire ER, Bouley CF, Reinert P. The effect of supplementation with milk fermented by Lactobacillus casei (strain . DN-114 001) on acute diarrhoea in children attending day care centres. Int J Clin Pract 1999;53:179-84.
26. Pelto 1998 Pelto L, Isolauri E, Lilius EM, Nuutila J, Salminen S. Probiotic bacteria downregulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clin Exp Allergy 1998;28:1474-9.
27. Pochapin 2000 Pochapin M. The effect of probiotics on Clostridium difficile diarrhea. Am Gastroenterol 2000;95(1 Suppl):S11-13.
28. Rembacken 1994 Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1994;344:1046-9.
29. Rolfe 2006 Rolfe VE, Fortun PJ, Hawkey CJ, Bath-Hextall F. Probiotics for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2006, Issue 4.[Art. No.: CD004826. DOI: 10.1002/14651858.CD004826.pub2]
30. Sartor 2005 Sartor RB. Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol 2005;21:44- 50.
31. Shanahan 2000 Shanahan F. Probiotics and inflammatory bowel disease: is there a scientific rationale?. Inflamm Bowel Dis 2000;6:107-15.